Research map: Evaluating the design and implementation challenges of the Centers for Medicare & Medicaid Services’ Cell and Gene Therapy Access Model

Back to the article

Papers in this map

  1. Understanding Sickle cell disease: Causes, symptoms, and treatment options · Chukwuka Elendu · 2023 · 160 citations · Cited by this paper
  2. Health care cost trajectories among patients with cancer and cardiometabolic comorbidities over a decade including the pandemic period · 2026 · Related
  3. Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist · Natasha K. Kekre · 2014 · 157 citations · Cited by this paper
  4. Principles and practices for successful gene therapy innovative contracting: Insights from a multistakeholder convening · 2026 · Related
  5. Gene therapy for sickle cell disease: moving from the bench to the bedside · Allistair Abraham · 2021 · 94 citations · Cited by this paper
  6. Timing of health technology assessment in the United States: An evaluation of ICER reviews over 8 years · 2026 · Related
  7. Selection in Health Insurance Markets and Its Policy Remedies · Michael Geruso · 2017 · 88 citations · Cited by this paper
  8. Incremental health care resource utilization, costs, and predictors of high costs in generalized myasthenia gravis · 2026 · Related
  9. The estimated annual financial impact of gene therapy in the United States · Chi Heem Wong · 2023 · 86 citations · Cited by this paper
  10. Cost-effectiveness analysis of treatment strategies initiating with second-generation antipsychotic long-acting injectables in patients with schizophrenia in the United States · 2026 · Related
  11. Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessment · Benjamin J. Peipert · 2022 · 82 citations · Cited by this paper
  12. Incidence of amyloid-related imaging abnormalities and health resource utilization in patients with Alzheimer disease receiving monoclonal antibody treatments: A real-world evidence study · 2026 · Related
  13. A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease · Patrick C. DeMartino · 2021 · 42 citations · Cited by this paper
  14. Patient experience data in formulary decision-making: Payer-reported perceptions and use · 2026 · Related
  15. The Economic Burden of Sickle Cell Disease in the United States · Jinhai Stephen Huo · 2018 · 40 citations · Cited by this paper
  16. US commercial health plan use of corticosteroids in step therapy protocols: Frequency and clinical appropriateness · 2026 · Related
  17. Assessment of Health Insurance Benefit Mandates for Fertility Preservation Among 11 US States · Ricardo Enrique Flores Ortega · 2021 · 33 citations · Cited by this paper
  18. Advancing the measurement of caregiver impact: Data collection priorities aligned with caregiver, health technology assessment, and policy stakeholders · 2026 · Related
  19. Cost-effectiveness of a hypothetical cell or gene therapy cure for sickle cell disease · Jonathan D. Salcedo · 2021 · 31 citations · Cited by this paper
  20. Shared visits vs incident-to billing for pharmacy services · 2026 · Related
  21. Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions · Jeremy G. Allen · 2023 · 26 citations · Cited by this paper
  22. βT87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for Ex Vivo Anti-sickling Activity in Human Erythroid Cells · Selami Demirci · 2020 · 25 citations · Cited by this paper
  23. Current and future treatments for sickle cell disease: From hematopoietic stem cell transplantation to in vivo gene therapy · Julia Ball · 2025 · 20 citations · Cited by this paper
  24. Value-Based Pharmaceutical Contracts: Value for Whom? · Joseph T. Kannarkat · 2019 · 14 citations · Cited by this paper
  25. Current state of gene therapy in sickle cell disease · Mei San Tang · 2024 · 14 citations · Cited by this paper
  26. National Alliance of Sickle Cell Centers Consensus Recommendations on Sickle Cell Disease Health Maintenance · Seethal A. Jacob · 2025 · 13 citations · Cited by this paper
  27. Enrollment patterns among medicaid beneficiaries with sickle cell disease: Multistate findings from the sickle cell data collection program · Ashima Singh · 2025 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)